Delivery Order SPE2DB22D2206-SPE2DB24FKA20

Award Date 8/27/24
Potential Completion Date 9/18/24
Potential Value $38K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $22,820.10 delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a completion date of June 3, 2024. The contract was competitively awarded and is a firm fixed-price type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,820.10 firm fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a period of performance through July 16, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $7,633.80 and an ultimate completion date of June 10, 2025. The contract is not set-aside and was awarded on May 19, 2025. AmerisourceBergen Drug Corporation holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,901.40 firm-fixed-price contract is for the delivery of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product. The contract has a period of performance through May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical sourcing and distribution services company. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $30,426.80 and a period of performance through April 17, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a pharmaceutical product, with a ceiling value of $30,535.20. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corporation is the prime contractor, and there is no...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $30,535.20 fixed-price delivery order is for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a medication used in the treatment of HIV. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has a ceiling value of $38,644.98 and an ultimate completion date of January 14, 2025. The contract covers the provision of a wide range of medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,373.24 and a period of performance through March 7, 2025. It is a firm fixed-price contract for the procurement of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,812.65 and an ultimate completion date of February 3, 2025. It is a firm-fixed-price contract for the delivery of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes,...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FKA20
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CABENUVA ER 600 MG-900 MG SUSP 6ML, a specialty medication. The contract has a ceiling value of $38,033.50 and is effective from August 27, 2024, to September 18, 2024. It is a Firm Fixed Price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued at up to $999,999,999 and $750,000, respectively, to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and federal healthcare needs nationwide.

Generated 11/26/24, 9:06 AM